大连医科大学学报
大連醫科大學學報
대련의과대학학보
JOURNAL OF DALIAN MEDICAL UNIVERSITY
2014年
6期
575-579
,共5页
氨甲环酸%经尿道前列腺电切术%出血
氨甲環痠%經尿道前列腺電切術%齣血
안갑배산%경뇨도전렬선전절술%출혈
tranexamic acid%TURP%haemorrhage
目的:探讨人工合成的抗纤溶药物氨甲环酸对接受经尿道前列腺电切术的患者失血量的影响及其安全性。方法2012年1月—2013年2月行经尿道前列腺电切术的60例患者,随机双盲分为氨甲环酸组( T组)和空白对照组( C组),每组30例。 T组在麻醉诱导后将氨甲环酸注射液1 g/200 mL(以20~40滴/min的速度)静滴完毕。 C组给予等量生理盐水同样的速度静滴完毕。比较两组术中、术后4 h、术后24 h的失血量,比较两组术前、术后4h凝血功能(凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原)的变化,观察术后7d内是否有下肢深静脉血栓或肺栓塞等并发症的发生。结果 T组术中失血量(102.0±11.4) mL及术后4 h的失血量(61.9±6.1)mL明显少于C组术中失血量(303.6±24.8)mL及术后4 h的失血量(84.8±15.2)mL,差异有显著性意义(P<0.05)。而两组术后24 h失血量比较差异无显著性意义。两组患者凝血指标的比较差异无显著性意义且两组患者均未发现下肢深静脉血栓或肺栓塞等并发症的发生。结论氨甲环酸可以明显降低经尿道前列腺电切术术中及术后4h的失血量,且未增加血栓形成的风险。
目的:探討人工閤成的抗纖溶藥物氨甲環痠對接受經尿道前列腺電切術的患者失血量的影響及其安全性。方法2012年1月—2013年2月行經尿道前列腺電切術的60例患者,隨機雙盲分為氨甲環痠組( T組)和空白對照組( C組),每組30例。 T組在痳醉誘導後將氨甲環痠註射液1 g/200 mL(以20~40滴/min的速度)靜滴完畢。 C組給予等量生理鹽水同樣的速度靜滴完畢。比較兩組術中、術後4 h、術後24 h的失血量,比較兩組術前、術後4h凝血功能(凝血酶原時間、活化部分凝血活酶時間、凝血酶時間、纖維蛋白原)的變化,觀察術後7d內是否有下肢深靜脈血栓或肺栓塞等併髮癥的髮生。結果 T組術中失血量(102.0±11.4) mL及術後4 h的失血量(61.9±6.1)mL明顯少于C組術中失血量(303.6±24.8)mL及術後4 h的失血量(84.8±15.2)mL,差異有顯著性意義(P<0.05)。而兩組術後24 h失血量比較差異無顯著性意義。兩組患者凝血指標的比較差異無顯著性意義且兩組患者均未髮現下肢深靜脈血栓或肺栓塞等併髮癥的髮生。結論氨甲環痠可以明顯降低經尿道前列腺電切術術中及術後4h的失血量,且未增加血栓形成的風險。
목적:탐토인공합성적항섬용약물안갑배산대접수경뇨도전렬선전절술적환자실혈량적영향급기안전성。방법2012년1월—2013년2월행경뇨도전렬선전절술적60례환자,수궤쌍맹분위안갑배산조( T조)화공백대조조( C조),매조30례。 T조재마취유도후장안갑배산주사액1 g/200 mL(이20~40적/min적속도)정적완필。 C조급여등량생리염수동양적속도정적완필。비교량조술중、술후4 h、술후24 h적실혈량,비교량조술전、술후4h응혈공능(응혈매원시간、활화부분응혈활매시간、응혈매시간、섬유단백원)적변화,관찰술후7d내시부유하지심정맥혈전혹폐전새등병발증적발생。결과 T조술중실혈량(102.0±11.4) mL급술후4 h적실혈량(61.9±6.1)mL명현소우C조술중실혈량(303.6±24.8)mL급술후4 h적실혈량(84.8±15.2)mL,차이유현저성의의(P<0.05)。이량조술후24 h실혈량비교차이무현저성의의。량조환자응혈지표적비교차이무현저성의의차량조환자균미발현하지심정맥혈전혹폐전새등병발증적발생。결론안갑배산가이명현강저경뇨도전렬선전절술술중급술후4h적실혈량,차미증가혈전형성적풍험。
Objective To determine the effect of tranexamic acid on perioperative blood loss in patients who underwent transurethral resection of the prostate ( TURP) , as well as its safety.Methods A double blind randomized control trial was conducted from January 2012 to February 2013.In this trial, 30 patients of the tranexamic acid group (T group), between age of 55-85 years, underwent TURP and received 1 g of tranexamic acid in 200 mL normal saline after induction of anes-thesia and 30 patients of the control group (C group) received a placebo (normal saline only).The medicine dripping speed ranged 20-40 drops/minute.The amount of blood loss was measured during the operation and at 4 h and 24 h post-operatively and the difference between the two groups was analyzed.Coagulation profiles, including prothrombin time, thrombin time and fibrinogen level, were measured preoperatively and 4 h postoperatively.Any signs of thromboembolic e-vent especially in the lower limbs or within 7 days were noted.Results The blood losses during operation and 4 h postopera-tion were (102.0 ±11.4) mL and (61.9 ±6.1) mL, respectively in the T group and (303.6 ±24.8) mL and (84.8 ± 15.2) mL, respectively in the C group.The values were significantly lower in the T group compared to those in the C group (P<0.05).However, there was no significant difference at 24 h postoperative blood loss between the groups.The coagu-lation profiles in the two groups were statistically not relevant.There was no evidence of deep vein thrombosis in the lower limbs or in both groups.Conclusion Tranexamic acid can reduce intraoperative blood loss during TURP without increasing the risk of thrombosis.